(CSL) Carlisle Companies - Overview
Sector: IndustrialsIndustry: Building Products & Equipment | Exchange NYSE (USA) | Currency USD | Market Cap: 13.390m | Total Return -2.7% in 12m
Stock: Roofing, Insulation, Waterproofing, Coatings, Building Envelope
Total Rating 50
Risk 92
Buy Signal -0.54
| Risk 5d forecast | |
|---|---|
| Volatility | 31.9% |
| Relative Tail Risk | -12.6% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.01 |
| Alpha | -18.02 |
| Character TTM | |
|---|---|
| Beta | 1.142 |
| Beta Downside | 0.844 |
| Drawdowns 3y | |
|---|---|
| Max DD | 37.72% |
| CAGR/Max DD | 0.41 |
EPS (Earnings per Share)
Revenue
Description: CSL Carlisle Companies March 05, 2026
Carlisle Companies Inc. (CSL) manufactures and supplies building envelope products. The company operates in two segments: Carlisle Construction Materials (CCM) and Carlisle Weatherproofing Technologies (CWT). The building envelope sector focuses on the physical separation between the interior and exterior of a building.
The CCM segment provides single-ply roofing solutions, including EPDM, TPO, and PVC membranes, as well as polyiso insulation and metal roofing systems. The CWT segment offers waterproofing, moisture protection, and air/vapor barrier products, along with sealants, roof coatings, and spray polyurethane foam. The companys business model involves manufacturing and distributing these materials for both commercial and residential applications.
CSL sells its products under various brands, such as Carlisle SynTec, Versico, and Hunter Panels. Consider exploring ValueRay for deeper insights into CSLs market position and financial performance.
Headlines to watch out for
- Commercial construction spending directly impacts roofing and weatherproofing demand
- Raw material cost fluctuations influence Carlisles manufacturing profitability
- Residential construction starts drive demand for building envelope products
- Regulatory changes in building codes affect product specifications and demand
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income: 740.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.15 > 0.02 and ΔFCF/TA -0.27 > 1.0 |
| NWC/Revenue: 30.71% < 20% (prev 25.19%; Δ 5.51% < -1%) |
| CFO/TA 0.18 > 3% & CFO 1.10b > Net Income 740.7m |
| Net Debt (1.77b) to EBITDA (1.22b): 1.45 < 3 |
| Current Ratio: 3.09 > 1.5 & < 3 |
| Outstanding Shares: last quarter (41.8m) vs 12m ago -11.25% < -2% |
| Gross Margin: 35.71% > 18% (prev 0.38%; Δ 3.53k% > 0.5%) |
| Asset Turnover: 83.11% > 50% (prev 86.02%; Δ -2.91% > 0%) |
| Interest Coverage Ratio: 13.09 > 6 (EBITDA TTM 1.22b / Interest Expense TTM 78.5m) |
Altman Z'' 8.30
| A: 0.25 (Total Current Assets 2.28b - Total Current Liabilities 736.0m) / Total Assets 6.26b |
| B: 1.17 (Retained Earnings 7.33b / Total Assets 6.26b) |
| C: 0.17 (EBIT TTM 1.03b / Avg Total Assets 6.04b) |
| D: 1.64 (Book Value of Equity 7.34b / Total Liabilities 4.47b) |
| Altman-Z'' Score: 8.30 = AAA |
Beneish M -3.06
| DSRI: 1.02 (Receivables 593.8m/579.7m, Revenue 5.02b/5.00b) |
| GMI: 1.06 (GM 35.71% / 37.73%) |
| AQI: 0.93 (AQ_t 0.51 / AQ_t-1 0.55) |
| SGI: 1.00 (Revenue 5.02b / 5.00b) |
| TATA: -0.06 (NI 740.7m - CFO 1.10b) / TA 6.26b) |
| Beneish M-Score: -3.06 (Cap -4..+1) = AA |
What is the price of CSL shares?
As of March 27, 2026, the stock is trading at USD 333.64 with a total of 362,743 shares traded.
Over the past week, the price has changed by +0.25%, over one month by -15.66%, over three months by +1.28% and over the past year by -2.68%.
Over the past week, the price has changed by +0.25%, over one month by -15.66%, over three months by +1.28% and over the past year by -2.68%.
Is CSL a buy, sell or hold?
Carlisle Companies has received a consensus analysts rating of 4.00.
Therefore, it is recommended to buy CSL.
- StrongBuy: 3
- Buy: 1
- Hold: 3
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the CSL price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 396.6 | 18.9% |
| Analysts Target Price | 396.6 | 18.9% |
CSL Fundamental Data Overview March 23, 2026
P/E Trailing = 19.0862
P/E Forward = 15.4799
P/S = 2.6674
P/B = 7.4571
P/EG = 1.0324
Revenue TTM = 5.02b USD
EBIT TTM = 1.03b USD
EBITDA TTM = 1.22b USD
Long Term Debt = 2.88b USD (from longTermDebt, last quarter)
Short Term Debt = 4.50m USD (from shortTermDebt, two quarters ago)
Debt = 2.88b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.77b USD (from netDebt column, last quarter)
Enterprise Value = 15.16b USD (13.39b + Debt 2.88b - CCE 1.11b)
Interest Coverage Ratio = 13.09 (Ebit TTM 1.03b / Interest Expense TTM 78.5m)
EV/FCF = 15.62x (Enterprise Value 15.16b / FCF TTM 970.6m)
FCF Yield = 6.40% (FCF TTM 970.6m / Enterprise Value 15.16b)
FCF Margin = 19.34% (FCF TTM 970.6m / Revenue TTM 5.02b)
Net Margin = 14.76% (Net Income TTM 740.7m / Revenue TTM 5.02b)
Gross Margin = 35.71% ((Revenue TTM 5.02b - Cost of Revenue TTM 3.23b) / Revenue TTM)
Gross Margin QoQ = 33.75% (prev 36.02%)
Tobins Q-Ratio = 2.42 (Enterprise Value 15.16b / Total Assets 6.26b)
Interest Expense / Debt = 0.96% (Interest Expense 27.7m / Debt 2.88b)
Taxrate = 22.62% (39.0m / 172.4m)
NOPAT = 794.9m (EBIT 1.03b * (1 - 22.62%))
Current Ratio = 3.09 (Total Current Assets 2.28b / Total Current Liabilities 736.0m)
Debt / Equity = 1.60 (Debt 2.88b / totalStockholderEquity, last quarter 1.80b)
Debt / EBITDA = 1.45 (Net Debt 1.77b / EBITDA 1.22b)
Debt / FCF = 1.82 (Net Debt 1.77b / FCF TTM 970.6m)
Total Stockholder Equity = 2.02b (last 4 quarters mean from totalStockholderEquity)
RoA = 12.26% (Net Income 740.7m / Total Assets 6.26b)
RoE = 36.69% (Net Income TTM 740.7m / Total Stockholder Equity 2.02b)
RoCE = 20.96% (EBIT 1.03b / Capital Employed (Equity 2.02b + L.T.Debt 2.88b))
RoIC = 18.05% (NOPAT 794.9m / Invested Capital 4.40b)
WACC = 8.36% (E(13.39b)/V(16.27b) * Re(10.0%) + D(2.88b)/V(16.27b) * Rd(0.96%) * (1-Tc(0.23)))
Discount Rate = 10.0% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -7.54%
[DCF] Terminal Value 78.08% ; FCFF base≈949.2m ; Y1≈1.01b ; Y5≈1.22b
[DCF] Fair Price = 447.1 (EV 20.05b - Net Debt 1.77b = Equity 18.28b / Shares 40.9m; r=8.36% [WACC]; 5y FCF grow 7.24% → 3.0% )
EPS Correlation: 9.65 | EPS CAGR: -2.33% | SUE: 0.77 | # QB: 0
Revenue Correlation: -34.74 | Revenue CAGR: -7.26% | SUE: 0.37 | # QB: 0
EPS next Quarter (2026-06-30): EPS=6.61 | Chg7d=+0.000 | Chg30d=-0.002 | Revisions Net=+2 | Analysts=10
EPS current Year (2026-12-31): EPS=20.81 | Chg7d=+0.000 | Chg30d=-0.016 | Revisions Net=+2 | Growth EPS=+7.3% | Growth Revenue=+1.2%
EPS next Year (2027-12-31): EPS=23.52 | Chg7d=+0.000 | Chg30d=+0.020 | Revisions Net=+5 | Growth EPS=+13.0% | Growth Revenue=+4.2%
[Analyst] Revisions Ratio: +0.25 (5 Up / 3 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 4.8% (Discount Rate 10.0% - Earnings Yield 5.2%)
[Growth] Growth Spread = -4.5% (Analyst 0.3% - Implied 4.8%)
P/E Forward = 15.4799
P/S = 2.6674
P/B = 7.4571
P/EG = 1.0324
Revenue TTM = 5.02b USD
EBIT TTM = 1.03b USD
EBITDA TTM = 1.22b USD
Long Term Debt = 2.88b USD (from longTermDebt, last quarter)
Short Term Debt = 4.50m USD (from shortTermDebt, two quarters ago)
Debt = 2.88b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.77b USD (from netDebt column, last quarter)
Enterprise Value = 15.16b USD (13.39b + Debt 2.88b - CCE 1.11b)
Interest Coverage Ratio = 13.09 (Ebit TTM 1.03b / Interest Expense TTM 78.5m)
EV/FCF = 15.62x (Enterprise Value 15.16b / FCF TTM 970.6m)
FCF Yield = 6.40% (FCF TTM 970.6m / Enterprise Value 15.16b)
FCF Margin = 19.34% (FCF TTM 970.6m / Revenue TTM 5.02b)
Net Margin = 14.76% (Net Income TTM 740.7m / Revenue TTM 5.02b)
Gross Margin = 35.71% ((Revenue TTM 5.02b - Cost of Revenue TTM 3.23b) / Revenue TTM)
Gross Margin QoQ = 33.75% (prev 36.02%)
Tobins Q-Ratio = 2.42 (Enterprise Value 15.16b / Total Assets 6.26b)
Interest Expense / Debt = 0.96% (Interest Expense 27.7m / Debt 2.88b)
Taxrate = 22.62% (39.0m / 172.4m)
NOPAT = 794.9m (EBIT 1.03b * (1 - 22.62%))
Current Ratio = 3.09 (Total Current Assets 2.28b / Total Current Liabilities 736.0m)
Debt / Equity = 1.60 (Debt 2.88b / totalStockholderEquity, last quarter 1.80b)
Debt / EBITDA = 1.45 (Net Debt 1.77b / EBITDA 1.22b)
Debt / FCF = 1.82 (Net Debt 1.77b / FCF TTM 970.6m)
Total Stockholder Equity = 2.02b (last 4 quarters mean from totalStockholderEquity)
RoA = 12.26% (Net Income 740.7m / Total Assets 6.26b)
RoE = 36.69% (Net Income TTM 740.7m / Total Stockholder Equity 2.02b)
RoCE = 20.96% (EBIT 1.03b / Capital Employed (Equity 2.02b + L.T.Debt 2.88b))
RoIC = 18.05% (NOPAT 794.9m / Invested Capital 4.40b)
WACC = 8.36% (E(13.39b)/V(16.27b) * Re(10.0%) + D(2.88b)/V(16.27b) * Rd(0.96%) * (1-Tc(0.23)))
Discount Rate = 10.0% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -7.54%
[DCF] Terminal Value 78.08% ; FCFF base≈949.2m ; Y1≈1.01b ; Y5≈1.22b
[DCF] Fair Price = 447.1 (EV 20.05b - Net Debt 1.77b = Equity 18.28b / Shares 40.9m; r=8.36% [WACC]; 5y FCF grow 7.24% → 3.0% )
EPS Correlation: 9.65 | EPS CAGR: -2.33% | SUE: 0.77 | # QB: 0
Revenue Correlation: -34.74 | Revenue CAGR: -7.26% | SUE: 0.37 | # QB: 0
EPS next Quarter (2026-06-30): EPS=6.61 | Chg7d=+0.000 | Chg30d=-0.002 | Revisions Net=+2 | Analysts=10
EPS current Year (2026-12-31): EPS=20.81 | Chg7d=+0.000 | Chg30d=-0.016 | Revisions Net=+2 | Growth EPS=+7.3% | Growth Revenue=+1.2%
EPS next Year (2027-12-31): EPS=23.52 | Chg7d=+0.000 | Chg30d=+0.020 | Revisions Net=+5 | Growth EPS=+13.0% | Growth Revenue=+4.2%
[Analyst] Revisions Ratio: +0.25 (5 Up / 3 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 4.8% (Discount Rate 10.0% - Earnings Yield 5.2%)
[Growth] Growth Spread = -4.5% (Analyst 0.3% - Implied 4.8%)